World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
110
Citations
38764
World Ranking
903
National Ranking
551

Medicine

D-Index
113
Citations
42814
World Ranking
4998
National Ranking
2711

Katherine S. Panageas publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Katherine S. Panageas sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 485 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Katherine S. Panageas D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Katherine S. Panageas sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Katherine S. Panageas is affiliated with Memorial Sloan Kettering Cancer Center in the United States, where their research focuses primarily on oncology and related medical fields. Their academic output spans over numerous studies related to cancer immunotherapy, brain metastases, and cancer genomics, among other specialized areas within medicine.

The scientist has contributed extensively to the field of oncology, with a substantial number of publications in prominent journals. Frequent publication venues include:

  • Journal of Clinical Oncology
  • Neuro-Oncology
  • JCO Oncology Practice
  • Regular and Young Investigator Award Abstracts
  • Cancer Research

Panageas's research topics cover a broad spectrum of subfields such as oncology, pulmonary and respiratory medicine, genetics, molecular biology, and complementary and alternative medicine. Their main topics of work include:

  • Cancer Immunotherapy and Biomarkers
  • Brain Metastases and Treatment
  • Glioma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Acupuncture Treatment Research Studies
  • Complementary and Alternative Medicine Studies

Collaboration plays a significant role in their work, with frequent co-authors such as Anne S. Reiner, Michael A. Postow, Jun J. Mao, Samantha Brown, and Margaret K. Callahan. This network highlights a collaborative approach spanning multiple studies across oncology research.

Recent notable publications by Panageas include:

  • "Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal," 2023, Cancer Research
  • "T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants," 2023, Cell
  • "Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade," 2020, Journal of Clinical Oncology
  • "Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors," 2021, JAMA Oncology
  • "Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity," 2021, Cancer Cell

The breadth of Panageas's work reflects an integration of clinical oncology, immunotherapy, and supportive treatment strategies such as acupuncture within the cancer treatment paradigm. This interdisciplinary scope is supported by their research interests in molecular biology and genetics, alongside more traditional medical oncology.

Best Publications

  • How To Build and Interpret a Nomogram for Cancer Prognosis

    Alexia Iasonos;Deborah Schrag;Ganesh V. Raj;Katherine S. Panageas

  • T-cell invigoration to tumour burden ratio associated with anti-PD-1 response

    Alexander C. Huang;Michael A. Postow;Michael A. Postow;Robert J. Orlowski;Rosemarie Mick

  • Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center

    Troy Z. Horvat;Nelly G. Adel;Thu-Oanh Dang;Parisa Momtaz

  • KIT as a therapeutic target in metastatic melanoma

    Richard D. Carvajal;Cristina R. Antonescu;Jedd D. Wolchok;Paul B. Chapman

  • Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma

    Paul B. Chapman;Lawrence H. Einhorn;Michael L. Meyers;Scott Saxman

  • Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification

    Andrew D. Seidman;Monica N. Fornier;Francisco J. Esteva;Lee Tan

  • Developing a Cancer-Specific Geriatric Assessment: A Feasibility Study

    Arti Hurria;Supriya Gupta;Marjorie Zauderer;Enid L. Zuckerman

  • Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model

    Lauren E. Abrey;Leah Ben-Porat;Katherine S. Panageas;Joachim Yahalom

  • Risk of Arterial Thromboembolism in Patients With Cancer

    Babak B. Navi;Anne S. Reiner;Hooman Kamel;Costantino Iadecola

  • Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

    Patrick G. Morris;Denise D. Correa;Joachim Yahalom;Jeffrey J. Raizer

  • Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting lymphocyte count after 2 doses correlates with survival

    Geoffrey Y. Ku;Jianda Yuan;David B. Page;Sebastian E. A. Schroeder

  • Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid

    Alexandra M. Miller;Ronak H. Shah;Elena I. Pentsova;Maryam Pourmaleki

  • Leptomeningeal metastases in the MRI era

    J.L. Clarke;H.R. Perez;L.M. Jacks;K.S. Panageas

  • Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid

    Jae H. Park;Baozhen Qiao;Katherine S. Panageas;Maria J. Schymura

  • Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma: A Randomized Clinical Trial

    Richard D. Carvajal;Jeffrey A. Sosman;Jorge Fernando Quevedo;Mohammed M. Milhem

  • Stroke in patients with cancer: Incidence and etiology

    D. M. Cestari;D. M. Weine;K. S. Panageas;A. Z. Segal

  • Hospital and Surgeon Procedure Volume as Predictors of Outcome Following Rectal Cancer Resection

    Deborah Schrag;Katherine S. Panageas;Elyn Riedel;Laura D. Cramer

  • Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

    Jianda Yuan;Matthew Adamow;Brian A. Ginsberg;Teresa S. Rasalan

  • The effect of clustering of outcomes on the association of procedure volume and surgical outcomes.

    Katherine S. Panageas;Deborah Schrag;Elyn Riedel;Peter B. Bach

  • R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

    Antonio Omuro;Denise D. Correa;Lisa M. DeAngelis;Craig H. Moskowitz

Frequent Co-Authors

Jedd D. Wolchok
Jedd D. Wolchok Cornell University
Michael A. Postow
Michael A. Postow Memorial Sloan Kettering Cancer Center
Paul B. Chapman
Paul B. Chapman Memorial Sloan Kettering Cancer Center
Lisa M. DeAngelis
Lisa M. DeAngelis Memorial Sloan Kettering Cancer Center
Daniel G. Coit
Daniel G. Coit Memorial Sloan Kettering Cancer Center
Lauren E. Abrey
Lauren E. Abrey University of Zurich
Richard D. Carvajal
Richard D. Carvajal Columbia University
Alan N. Houghton
Alan N. Houghton Memorial Sloan Kettering Cancer Center
Jianda Yuan
Jianda Yuan MSD (United States)
Larry Norton
Larry Norton Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Medicine but seeking alternative routes or complementary healthcare careers, numerous online degree options are available. Careers in healthcare administration, nursing practice, pharmacy, and health information management are all accessible via flexible online programs, making it easier for working students or professionals to advance their education.

If you aspire to lead in healthcare organizations, consider exploring the cheapest mha programs online healthcare. These affordable Master of Healthcare Administration degrees offer a pathway into high-demand leadership roles.

For registered nurses aiming to advance their clinical knowledge and leadership potential, the best dnp programs online provide an efficient way to earn a Doctor of Nursing Practice without disrupting your career.

Pharmacists can now qualify through online pharmacy schools, offering flexibility and affordability compared to traditional campus-based programs.

Additionally, professionals looking to specialize in medical records or data analysis might consider rhia certification programs online to become registered health information administrators and support patient care using data-driven technologies.

Best Scientists Citing Katherine S. Panageas

Trending Scientists

Recently Published Articles